Liver cirrhosis induced by delta virus: clinical and evolutive pecularities in patients on the waiting list for liver transplantation in Republic of Moldova
Закрыть
Articolul precedent
Articolul urmator
104 1
Ultima descărcare din IBN:
2024-04-11 18:38
SM ISO690:2012
. Liver cirrhosis induced by delta virus: clinical and evolutive pecularities in patients on the waiting list for liver transplantation in Republic of Moldova. In: Perspectives of the Balkan medicine in the post COVID-19 era: The 37th Balkan Medical Week. The 8th congress on urology, dialysis and kidney transplant from the Republic of Moldova “New Horizons in Urology”, Ed. 37, 7-9 iunie 2023, Chişinău. București: Balkan Medical Union, 2023, Ediția 37, p. 143. ISSN Print: ISSN 1584-9244 ISSN-L 1584-9244 Online: ISSN 2558-815X.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Perspectives of the Balkan medicine in the post COVID-19 era
Ediția 37, 2023
Congresul "Perspectives of the Balkan medicine in the post COVID-19 era"
37, Chişinău, Moldova, 7-9 iunie 2023

Liver cirrhosis induced by delta virus: clinical and evolutive pecularities in patients on the waiting list for liver transplantation in Republic of Moldova


Pag. 143-143

, , , ,
 
”Nicolae Testemițanu” State University of Medicine and Pharmacy
 
Proiecte:
 
Disponibil în IBN: 21 decembrie 2023


Rezumat

Introduction. Evolution of liver cirrhosis induced by delta virus is more severe in comparison with monoinfection HBV being grevated by numerous complications. The aim of this study was to compare clinical evolution of patients with liver cirrhosis induced by delta and B viral infection that are on the waiting list for liver transplantation in Republic of Moldova. Material and Methods. In side of the national transplant program was performed a retrospective study on two groups of patients with liver cirrhosis that are on the waiting list for liver transplant since february 2013 to December 2022. In each group were included 40 patients (1st group – patients diagnosed with liver cirrhosis of HBV/ HDV etiology, 2nd group - patients diagnosed with liver cirrhosis of HBV etiology). Results. After the analysis of the groups, statistical difference was recorded on the average age of the patients (group I vs group II being 48.55 ± 9.01 vs 55.81 ± 5.85, p = 0.01). The mean MELD score at inclusion in the waiting list was 16.15 ± 3.91 group I vs 15.11 ± 3.26 points for group II (p = <0.0001). The statistical difference between clinical development and the presence of complications from the time of inclusion in the waiting list has not been identified. Thus, ascites were recorded in 77.5% patients in group I vs 54.5% group II (p = 0.8); upper digestive haemorrhage - 40% group I vs 18% group II (p = 0.9); HCC - 20% group I vs. 15% group II (p = 0.41); portal vein thrombosis - 18% group I vs. 4.5% group II (p = 0.5); spontaneous bacterial peritonitis - 2% group I vs 0.9% group II (p = 0.2). Patients in group I (35%) vs group II (17%) had lower survival (p = 0.014). Conclusion. Although VHD infection is not an independent mortality predictive factor, it imparts a more aggressive course of evolution. The complications appeared were not influenced by the etiology of the disease. Patients with liver cirrhosis HBV / HDV during the follow-up period had significantly less survival compared to patients with HBV liver cirrhosis (p = 0.014).